$9.18 +0.23 (%) Exelixis Inc - NASDAQ

Jul. 29, 2016 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Benzinga's Top #PreMarket Gainers

    Benzinga | Jan. 5, 2016 | 08:13AM EST
  2. 5 Stocks You Should Be Watching Today

    Benzinga | Jan. 5, 2016 | 04:30AM EST
  3. The Best-Performing Non-S&P Stocks of 2015

    GuruFocus | Dec. 30, 2015 | 16:01PM EST
  4. Top-Performing Non-S&P 500 Stocks of the Year

    GuruFocus | Dec. 30, 2015 | 16:01PM EST
  5. Top Stocks 2015: Biotechs, Wayfair, Netflix, Amazon

    IBD | Dec. 30, 2015 | 08:02AM EST
  6. Exelixis Announces Presentation of Positive Overall Survival Results for COTELLIC in Combination with Vemurafenib in Advanced BRAF V600 Mutation-Positive Melanoma at Society for Melanoma Research 2015 International Congress

    Benzinga | Nov. 21, 2015 | 20:54PM EST
  7. Morning Market Gainers

    Benzinga | Oct. 6, 2015 | 09:43AM EST
  8. Benzinga's Top #PreMarket Gainers

    Benzinga | Oct. 6, 2015 | 08:16AM EST
  9. Exelixis Announces Positive Overall Survival Results from coBRIM Phase 3 Pivotal Trial

    Benzinga | Oct. 6, 2015 | 04:23AM EST
  10. Morning Market Losers

    Benzinga | Sep. 28, 2015 | 09:59AM EST
  11. Benzinga's Top #PreMarket Losers

    Benzinga | Sep. 28, 2015 | 08:25AM EST
  12. Jim Cramer Shares His Thoughts On Home Depot, Bristol-Myers Squibb, Marathon Oil, Exelixis

    Benzinga | Sep. 16, 2015 | 06:34AM EST
  13. Morning Market Gainers

    Benzinga | Aug. 27, 2015 | 09:43AM EST
  14. Benzinga's Top #PreMarket Gainers

    Benzinga | Aug. 27, 2015 | 08:12AM EST
  15. Benzinga's Top #PreMarket Gainers

    Benzinga | Aug. 25, 2015 | 08:14AM EST
  16. Exelixis Prices 25M Share Offering @$5.40/Share

    Benzinga | Jul. 23, 2015 | 20:50PM EST
  17. Benzinga's Top #PreMarket Losers

    Benzinga | Jul. 21, 2015 | 08:16AM EST
  18. Ethical-Drug Firms Horizon Pharma, Bristol-Myers Rally

    IBD | Jul. 20, 2015 | 18:50PM EST
  19. Bristol-Myers: kidney drug win

    IBD | Jul. 20, 2015 | 18:41PM EST
  20. Market Update: Monday's Mid-Day Movers; Greece Opens Banks; Gold Dwindles

    Benzinga | Jul. 20, 2015 | 12:03PM EST
  21. Bristol-Myers, Exelixis Drugs Score Vs. Kidney Cancer

    IBD | Jul. 20, 2015 | 10:50AM EST
  22. Mid-Morning Market Update: Markets Mostly Flat; Morgan Stanley Beats Q2 Views

    Benzinga | Jul. 20, 2015 | 10:18AM EST
  23. Benzinga's Top #PreMarket Gainers

    Benzinga | Jul. 20, 2015 | 08:08AM EST
  24. Exelixis Announces Start of Phase 1 Trial of Cabozantinib in Combination with Nivolumab or Nivolumab Plus Ipilimumab in Patients with Advanced/Metastatic Urothelial Carcinoma and Other Genitourinary Tumors

    Benzinga | Jul. 13, 2015 | 08:30AM EST
  25. Benzinga's Top #PreMarket Losers

    Benzinga | Jun. 29, 2015 | 08:18AM EST
  26. Watch These 10 Stocks Over The Weekend

    Benzinga | Jun. 20, 2015 | 11:31AM EST
  27. Morning Market Gainers

    Benzinga | Jun. 1, 2015 | 10:16AM EST
  28. Benzinga's Top #PreMarket Gainers

    Benzinga | Jun. 1, 2015 | 08:08AM EST
  29. Morning Market Gainers

    Benzinga | Feb. 19, 2015 | 09:46AM EST
  30. Benzinga's Top #PreMarket Gainers

    Benzinga | Feb. 19, 2015 | 08:13AM EST
  31. Exelixis Data Release Upcoming; Options Activity Spiking

    Benzinga | Feb. 5, 2015 | 15:37PM EST
  32. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 4

    Benzinga | Jan. 13, 2015 | 11:34AM EST
  33. 5-year lows: Synta Pharmaceuticals Inc, Exelixis Inc, Entropic Communications Inc, and ...

    GuruFocus | Dec. 28, 2014 | 17:09PM EST
  34. Mid-Day Market Update: ON Semiconductor Surges On $1 Billion Buyback Plan; POZEN Shares Slip

    Benzinga | Dec. 1, 2014 | 13:43PM EST
  35. Mid-Morning Market Update: Markets Open Lower; Weatherford To Sell Engineered Chemistry, Drilling Fluid Operations to Berkshire's Lubrizol

    Benzinga | Dec. 1, 2014 | 10:23AM EST
  36. Morning Market Losers

    Benzinga | Dec. 1, 2014 | 09:53AM EST
  37. Events for the Week of Nov. 17-21, 2014

    Benzinga | Nov. 17, 2014 | 13:13PM EST
  38. Morning Market Movers

    Benzinga | Sep. 29, 2014 | 09:36AM EST
  39. 5-year lows: National Presto Industries, Ennis Inc, Landauer Inc, and Exelixis Inc.

    GuruFocus | Sep. 28, 2014 | 20:41PM EST
  40. Stocks Hitting 52-Week Lows

    Benzinga | Sep. 15, 2014 | 10:09AM EST
  41. Equities, Commodities & Bonds Finish Lower On First Trading Day Of The Month

    Benzinga | Sep. 2, 2014 | 16:34PM EST
  42. Midday Losers From Tuesday, September 2

    Benzinga | Sep. 2, 2014 | 14:15PM EST
  43. Exelixis Shares Slide On Trial Results; Norwegian Cruise Line Surges

    Benzinga | Sep. 2, 2014 | 12:54PM EST
  44. Markets Mixed; Conn's Profit Misses Estimates

    Benzinga | Sep. 2, 2014 | 11:15AM EST
  45. Stocks Hitting 52-Week Lows

    Benzinga | Sep. 2, 2014 | 10:16AM EST
  46. Morning Market Losers

    Benzinga | Sep. 2, 2014 | 09:52AM EST
  47. Benzinga's Top Downgrades

    Benzinga | Sep. 2, 2014 | 08:53AM EST
  48. Stifel Nicolaus Downgrades Exelixis To Hold

    Benzinga | Sep. 2, 2014 | 08:24AM EST
  49. Stocks To Watch For September 2, 2014

    Benzinga | Sep. 2, 2014 | 04:05AM EST
  50. Exelixis Announces Results From COMET-1 Phase 3 Pivotal Trial Of Cabozantinib In Men W/ Metastatic Castration-Resistant Prostate Cancer; DId Not Meet Primary Endpoint

    Benzinga | Sep. 1, 2014 | 18:50PM EST
Trading Center